Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 6/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Asia Vital Components Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$769.00 |
52 Week High | NT$817.00 |
52 Week Low | NT$192.50 |
Beta | 0.84 |
1 Month Change | 17.58% |
3 Month Change | 42.67% |
1 Year Change | 280.69% |
3 Year Change | 993.88% |
5 Year Change | 2,244.51% |
Change since IPO | 3,039.66% |
Recent News & Updates
Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce
May 29We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease
May 21Recent updates
Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce
May 29We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease
May 21Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?
Apr 17A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Apr 03Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)
Mar 21Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher
Feb 26Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?
Apr 23Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?
Apr 08Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Mar 21Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?
Feb 16Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?
Jan 17Asia Vital Components (TPE:3017) Seems To Use Debt Quite Sensibly
Jan 02Why Asia Vital Components Co., Ltd. (TPE:3017) Is A Dividend Rockstar
Dec 20Is Now An Opportune Moment To Examine Asia Vital Components Co., Ltd. (TPE:3017)?
Dec 07Is There More To The Story Than Asia Vital Components's (TPE:3017) Earnings Growth?
Nov 24Shareholder Returns
3017 | TW Tech | TW Market | |
---|---|---|---|
7D | 8.9% | 0.04% | -0.8% |
1Y | 280.7% | 63.8% | 27.9% |
Return vs Industry: 3017 exceeded the TW Tech industry which returned 63.8% over the past year.
Return vs Market: 3017 exceeded the TW Market which returned 27.9% over the past year.
Price Volatility
3017 volatility | |
---|---|
3017 Average Weekly Movement | 10.0% |
Tech Industry Average Movement | 5.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in TW Market | 8.6% |
10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 3017's share price has been volatile over the past 3 months.
Volatility Over Time: 3017's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | n/a | Ching-Hang Shen | www.avc.co |
Asia Vital Components Co., Ltd. provides thermal solutions worldwide. The company offers DC, EC, and thin centrifugal fans; and fan arrays, far-end radiators, radiators, compressor radiators, heat sinks, and heat pipes/vapor chambers. It also designs and manufactures PC related casing systems.
Asia Vital Components Co., Ltd. Fundamentals Summary
3017 fundamental statistics | |
---|---|
Market cap | NT$294.77b |
Earnings (TTM) | NT$5.86b |
Revenue (TTM) | NT$62.67b |
50.3x
P/E Ratio4.7x
P/S RatioIs 3017 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3017 income statement (TTM) | |
---|---|
Revenue | NT$62.67b |
Cost of Revenue | NT$49.24b |
Gross Profit | NT$13.42b |
Other Expenses | NT$7.56b |
Earnings | NT$5.86b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 15.29 |
Gross Margin | 21.42% |
Net Profit Margin | 9.35% |
Debt/Equity Ratio | 47.4% |
How did 3017 perform over the long term?
See historical performance and comparison